Physicians may inadequately counsel inflammatory bowel disease patients about immunosuppressive therapy and risk of nonmelanoma skin cancer

Inflamm Bowel Dis. 2011 May;17(5):1246. doi: 10.1002/ibd.20979.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adult
  • Counseling / standards*
  • Female
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Inflammatory Bowel Diseases / drug therapy*
  • Inflammatory Bowel Diseases / epidemiology*
  • Male
  • Physician-Patient Relations
  • Risk Factors
  • Skin Neoplasms / epidemiology*

Substances

  • Immunosuppressive Agents